- Home
- Clinical Resources Search
- PQI Podcast S6 Ep 12: IV Iron Therapy
S6 Eps 12: IV Iron Therapy
Last Updated: April 11, 2024
By: Ginger Blackmon, PharmD | Layla Van Doren, MD, MBA | Kristen Boykin, PharmD, BCOP, BCPS

This week, we sit down with Layla Van Doren, MD, MBA, and Kristen Boykin, PharmD, BCOP, BCPS, to discuss IV iron therapy.
Dr. Van Doren is a hematologist with Yale New Haven Health and Director of Education in the Adult Sickle Cell Program. Kristen is the Director of Pharmacy Operations at Florida Cancer Specialists and Research Institute.
This podcast episode is sponsored by Pharmacosmos Therapeutics Inc.
Pharmacosmos Therapeutics Inc. is a U.S. specialty pharmaceutical company dedicated to providing patient care through the commercialization of Monoferric® (ferric derisomaltose) injection and through exceptional resources to support this treatment. We are the U.S. affiliate of the Denmark-based Pharmacosmos Group. Please visit us at www.monoferric.com to learn more.
Related Content
S9 E13: A Season of Gratitude
S9 E12: “We Won the Battle, Now Let’s Paddle”
S9 E11: Honoring Veterans Through Early Cancer Detection
S9 E10: Advancing Clinical Research
PQI: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)
Eltrombopag
Voxelotor
PQI Podcast S5 Ep 12: Intravenous Iron Products for Anemia-Related Chemotherapy & Cancer
S9 E13: A Season of Gratitude
S9 E12: “We Won the Battle, Now Let’s Paddle”
Zongertinib
Elotuzumab and Pd
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields
Was this page
helpful?
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields




